NeuroGenesis and Hadassah Medical Center announced highly positive results from a placebo-controlled Phase 2 clinical trial assessing the impact of […]
TG Therapeutics announced positive topline results from two global, active-controlled, Phase 3 studies, called ULTIMATE I & II, evaluating ublituximab […]
Kintara Therapeutics announced interim data on its two Phase 2 trials of VAL-083 for the treatment of glioblastoma multiforme (GBM). […]
Brainstorm Cell Therapeutics reported topline results from a Phase 3 trial evaluating NurOwn (MSC-NTF cells) as a treatment for Amyotrophic […]
Dr. Colbey W. Freeman and colleagues in the Perelman School of Medicine at the University of Pennsylvania looked at COVID-19 […]
In addition to the stages (incubation, symptomatic, early pulmonary & late pulmonary) associated with a SARS-CoV-2 infection, known as COVID-19, two […]
Biogen reported its Q3 2020 financial results, highlighting that its total revenues had reached $3.3 million. However, this was a […]
Voyager Therapeutics announced the FDA placed a clinical hold on the company’s Investigational New Drug (IND) application for VY-HTT01 for the […]
Sage Therapeutics announced interim, topline results from a July data cut of the ongoing Phase 3 open-label SHORELINE Study. This […]
Nearly 80% of people taking calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs) for the preventive treatment of migraine reported their […]
